Full Text View
Tabular View
No Study Results Posted
Related Studies
The Effectiveness of Commercial Weight Loss Programmes
This study has been completed.
First Received: May 17, 2006   Last Updated: July 20, 2006   History of Changes
Sponsors and Collaborators: University of Surrey
British Broadcasting Corporation
Information provided by: University of Surrey
ClinicalTrials.gov Identifier: NCT00327821
  Purpose

The objective is to compare the effectiveness of 4 different commercial weight-loss diets available to adults in the UK.

This is achieved with a 6 month multi-centre randomised unblinded controlled trial of

  • Dr Atkins' New Diet Revolution,
  • The slimFast Plan,
  • The weight Watchers Pure Points Programme,
  • Rosemary Conley's "Eat Yourself Slim" Diet & Fitness Plan.
  • No diet (control)

Subjects are a community based sample of 300 (60 per group) otherwise healthy overweight and obese adults.

Main outcome measures are weight and body fat change over 6 months.


Condition Intervention
Obesity
Behavioral: calorie controlled diet

MedlinePlus related topics: Diets Obesity Weight Control
U.S. FDA Resources
Study Type: Interventional
Study Design: Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title: A Randomised Control Trial of Commercial Weight Loss Programme in a Community Based Sample of Obese Adults.

Further study details as provided by University of Surrey:

Primary Outcome Measures:
  • Weight loss
  • Fat loss

Estimated Enrollment: 300
Study Start Date: July 2002
Estimated Study Completion Date: March 2003
  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Body mass index (BMI) > 27 and < 40 kg/m2.

Exclusion Criteria:

  • History of coronary heart disease
  • Type 1 or Type 2 diabetes
  • Renal, liver or respiratory failure
  • Gout
  • Taking lipid lowering or anti-hypertensive drugs
  • History of obesity with known cause (i.e. Cushings disease, hypothyroidism)
  • Previous gastric or weight loss surgery
  • Taking any weight loss drug (including Orlistat or Sibutramine)
  • Clinical depression
  • Eating disorders
  • Drug or alcohol abuse
  • Any malabsorptive state (including lactose intolerance)
  • Being treated for a malignancy
  • Being pregnant
  • Breastfeeding
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00327821

Locations
United Kingdom, Surrey
University of Surrey
Guildford, Surrey, United Kingdom, GU2 7XH
Sponsors and Collaborators
University of Surrey
British Broadcasting Corporation
Investigators
Principal Investigator: D J Millward, PhD University of Surrey
Study Director: H A Truby, PhD SRD University of Surrey
  More Information

Publications:
Additional publications automatically indexed to this study by National Clinical Trials Identifier (NCT ID):
Study ID Numbers: 107189 BBC
Study First Received: May 17, 2006
Last Updated: July 20, 2006
ClinicalTrials.gov Identifier: NCT00327821     History of Changes
Health Authority: United Kingdom: National Health Service

Study placed in the following topic categories:
Body Weight
Signs and Symptoms
Obesity
Weight Loss
Body Weight Changes
Nutrition Disorders
Overweight
Overnutrition

Additional relevant MeSH terms:
Body Weight
Signs and Symptoms
Obesity
Weight Loss
Body Weight Changes
Nutrition Disorders
Overweight
Overnutrition

ClinicalTrials.gov processed this record on May 07, 2009